Enzymatic Therapy
Artery Advantage
- Serving
- 1 Enteric-Coated Tablet(s)
- Material
- tablet
- UPC
- 763948028832
- DSLD ID
- 77464
Supplement Facts
6 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Vitamin B6UNII KV2JZ1BI6Z | 20 mg | 1000% |
| FolateUNII 935E97BOY8 | 800 mcg | 200% |
| Vitamin B12UNII 8406EY2OQA | 400 mcg | 6667% |
| Garlic Bulb Extract | 320 mg | — |
| Pomegranate Fruit Extract | 50 mg | — |
| Vitamin K2UNII 71ANL51TLA | 45 mcg | — |
Flagged excipients
1 flagged · authority citations below
- avoidTitanium Dioxide
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
Other ingredients
Cellulose · Rice Dextrin · Sodium Croscarmellose · Hypromellose · Silicon Dioxide · Magnesium Stearate · Sodium Alginate · Ethylcellulose · Hydroxypropyl Cellulose · Glycerin · Medium Chain Triglycerides · Oleic Acid · Stearic Acid